Evaluation status available after sign-in
About the journal
Australian Prescriber is an open-access journal published by Therapeutic Guidelines Ltd in Australia, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 36 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Therapeutic Guidelines Ltd
- ISSN
- 0312-8008 · 1839-3942
- Country
- Australia
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 0
- Declared review time
- 36 weeks
- Declared peer-review model
- other
- Official website
- https://australianprescriber.tg.org.au
Index listings
- DOAJ · 2018-07-27
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 36 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
36weeks
Works in OpenAlex
3209
Last recorded publication year
2025
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
61
i10-index
442
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2023-09-21
- Added to DOAJ
- 2018-07-27
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 56%
- Enrolled in Crossref Similarity Check
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 7804938
Classification4
Subjects (DOAJ)
Medicine: Therapeutics. PharmacologyMedicine: Pharmacy and materia medica
LCC codes
RM1-950RS1-441
Subject areas
- Pharmacy and Medical Practices
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Economics and Policy
- Pharmaceutical industry and healthcare
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
Show all subjects (75)
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Pain Management and Opioid Use
- Blood Pressure and Hypertension Studies
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical industry and healthcare
- Pharmaceutical industry and healthcare
- Treatment of Major Depression
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacological Effects and Toxicity Studies
- Pharmacological Effects and Toxicity Studies
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Medical research and treatments
- Antibiotic Use and Resistance
- Asthma and respiratory diseases
- Diabetes Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Regulation
- Opioid Use Disorder Treatment
- Dermatology and Skin Diseases
- Pregnancy and Medication Impact
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Atrial Fibrillation Management and Outcomes
- Anesthesia and Pain Management
- Blood Coagulation and Thrombosis Mechanisms
- Clinical practice guidelines implementation
- Schizophrenia research and treatment
- Pharmacology and Obesity Treatment
- Pharmacology and Obesity Treatment
- Anesthesia and Sedative Agents
- Anesthesia and Sedative Agents
- Epilepsy research and treatment
- Epilepsy research and treatment
- Electroconvulsive Therapy Studies
- Electroconvulsive Therapy Studies
- HIV/AIDS drug development and treatment
- Chronic Lymphocytic Leukemia Research
- HIV/AIDS drug development and treatment
- Chronic Lymphocytic Leukemia Research
- Drug-Induced Adverse Reactions
- Drug-Induced Adverse Reactions
- Pain Management and Opioid Use
- Pain Management and Opioid Use
- Poisoning and overdose treatments
- Poisoning and overdose treatments
- Health Sciences Research and Education
- Diabetes Treatment and Management
- Primary Care and Health Outcomes
- Health Sciences Research and Education
- Diabetes Treatment and Management
- Schizophrenia research and treatment
- Primary Care and Health Outcomes
- Schizophrenia research and treatment
- Atrial Fibrillation Management and Outcomes
- Treatment of Major Depression
- Treatment of Major Depression
- Atrial Fibrillation Management and Outcomes
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
Keywords (DOAJ)
- therapeutics
- drugs
- pharmacy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ